이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Integral Diagnostics 관리
관리 기준 확인 2/4
Integral Diagnostics' CEO는 Ian Kadish, May2017 에 임명되었습니다 의 임기는 7.08 년입니다. 총 연간 보상은 A$ 1.10M, 71.2% 로 구성됩니다. 71.2% 급여 및 28.8% 보너스(회사 주식 및 옵션 포함). 는 A$ 1.43M 가치에 해당하는 회사 주식의 0.24% 직접 소유합니다. 1.43M. 경영진과 이사회의 평균 재임 기간은 각각 3.8 년과 1.9 년입니다.
주요 정보
Ian Kadish
최고 경영자
AU$1.1m
총 보상
| CEO 급여 비율 | 71.2% |
| CEO 임기 | 7.2yrs |
| CEO 소유권 | 0.2% |
| 경영진 평균 재임 기간 | 3.8yrs |
| 이사회 평균 재임 기간 | 2yrs |
최근 관리 업데이트
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Sep 20Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Sep 11Could Integral Diagnostics Limited (ASX:IDX) Have The Makings Of Another Dividend Aristocrat?
Sep 03CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$58m |
| Sep 30 2023 | n/a | n/a | -AU$16m |
| Jun 30 2023 | AU$1m | AU$782k | AU$25m |
| Mar 31 2023 | n/a | n/a | AU$23m |
| Dec 31 2022 | n/a | n/a | AU$21m |
| Sep 30 2022 | n/a | n/a | AU$18m |
| Jun 30 2022 | n/a | AU$781k | AU$15m |
| Mar 31 2022 | n/a | n/a | AU$18m |
| Dec 31 2021 | n/a | n/a | AU$22m |
| Sep 30 2021 | n/a | n/a | AU$26m |
| Jun 30 2021 | AU$2m | AU$736k | AU$31m |
| Mar 31 2021 | n/a | n/a | AU$32m |
| Dec 31 2020 | n/a | n/a | AU$32m |
| Sep 30 2020 | n/a | n/a | AU$28m |
| Jun 30 2020 | AU$1m | AU$635k | AU$23m |
| Mar 31 2020 | n/a | n/a | AU$22m |
| Dec 31 2019 | n/a | n/a | AU$21m |
| Sep 30 2019 | n/a | n/a | AU$21m |
| Jun 30 2019 | AU$876k | AU$549k | AU$21m |
| Mar 31 2019 | n/a | n/a | AU$19m |
| Dec 31 2018 | n/a | n/a | AU$17m |
| Sep 30 2018 | n/a | n/a | AU$16m |
| Jun 30 2018 | AU$711k | AU$489k | AU$15m |
보상 대 시장: Ian 의 총 보상 ($USD 732.30K )은 Australian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 783.32K ).
보상과 수익: 회사가 수익성이 없는 동안 Ian 의 보상이 증가했습니다.
CEO
Ian Kadish (61 yo)
7.2yrs
테뉴어
AU$1,097,723
보상
Dr. Ian Kadish, MBBCh, MBA, has been the Chief Executive Officer, Managing Director and Director at Integral Diagnostics Limited since May 22, 2017. Dr. Kadish serves as Independent Non-Executive Director...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, MD & Director | 7.2yrs | AU$1.10m | 0.24% A$ 1.4m | |
| Executive Director | 4.7yrs | AU$1.05m | 0.011% A$ 65.2k | |
| Chief Financial Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Information Officer | 4.8yrs | 데이터 없음 | 데이터 없음 | |
| General Counsel & Company Secretary | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Medical Officer | 3yrs | 데이터 없음 | 데이터 없음 |
3.8yrs
평균 재임 기간
경험이 풍부한 관리: IDX 의 관리팀은 경험 ( 3.8 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, MD & Director | no data | AU$1.10m | 0.24% A$ 1.4m | |
| Executive Director | 4.7yrs | AU$1.05m | 0.011% A$ 65.2k | |
| Independent Non-Executive Director | 6.8yrs | AU$137.50k | 0.013% A$ 80.2k | |
| Independent Non-Executive Director | 2yrs | AU$131.77k | 0.036% A$ 220.2k | |
| Independent Non-Executive Director | less than a year | 데이터 없음 | 0.015% A$ 90.6k | |
| Independent Non-Executive Director | less than a year | 데이터 없음 | 0.065% A$ 392.9k |
2.0yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: IDX 의 이사회는 경험(평균 재직 기간 1.9 년)으로 간주되지 않으므로 새 이사회가 필요합니다.